ConductScience.org, home

Paper39596173

Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study.

Ge F and 8 others. Int J Mol Sci, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study. Papers, record 39596173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.21, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ge FFei
2Sun YYu
3Han CCCong-Cong
4Wei ZLZi-Liang
5Guan XXin
6Guo SWSi-Wan
7Quan SShui
8Zhou JGJia-Guo
9Pang RPRui-Ping

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mendelian Randomization AnalysisMajor topic
HypertensionMajor topic
Genome-Wide Association StudyMajor topic
GlucosamineMajor topic
Quantitative Trait LociMajor topic
Humans
Polymorphism, Single Nucleotide
Dietary Supplements
Genetic Predisposition to Disease
Aminoacyltransferases

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2021YFA0805100National Key R&D Program of ChinaPubMed
U21A20342National Natural Science Foundation of ChinaPubMed
81930106National Natural Science Foundation of ChinaPubMed
82170545National Natural Science Foundation of ChinaPubMed
2022A1515011872National Natural Science Foundation of GuangdongPubMed
2019A1515011295National Natural Science Foundation of GuangdongPubMed
N/AHigh-level Health Team Foundation of Zhuhai (2018)PubMed

Source PubMed

Download CSV of grants

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136029480Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies.Pharmacoepidemiol Drug Saf2022https://conductscience.org/library/papers/36029480PubMed
227061298Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.Genet Epidemiol2016https://conductscience.org/library/papers/27061298PubMed
338632649Osteoarthritis and hypertension: observational and Mendelian randomization analyses.Arthritis Res Ther2024https://conductscience.org/library/papers/38632649PubMed
47134225Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal.Pharmatherapeutica1982https://conductscience.org/library/papers/7134225PubMed
518756654Glucosamine.Am Fam Physician2008https://conductscience.org/library/papers/18756654PubMed
618363538Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.Pharmacotherapy2008https://conductscience.org/library/papers/18363538PubMed
729126136DrugBank 5.0: a major update to the DrugBank database for 2018.Nucleic Acids Res2018https://conductscience.org/library/papers/29126136PubMed
838807172Blood metabolites and chronic kidney disease: a Mendelian randomization study.BMC Med Genomics2024https://conductscience.org/library/papers/38807172PubMed
936635386Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.Nat Genet2023https://conductscience.org/library/papers/36635386PubMed
1035284849Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement.Am J Prev Cardiol2022https://conductscience.org/library/papers/35284849PubMed
1133961203Mendelian randomisation for mediation analysis: current methods and challenges for implementation.Eur J Epidemiol2021https://conductscience.org/library/papers/33961203PubMed
1234425883
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD.
Alzheimers Res Ther2021https://conductscience.org/library/papers/34425883PubMed
1329875488Genomic atlas of the human plasma proteome.Nature2018https://conductscience.org/library/papers/29875488PubMed
1428527048Interpreting findings from Mendelian randomization using the MR-Egger method.Eur J Epidemiol2017https://conductscience.org/library/papers/28527048PubMed
1525939054Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality.Annu Rev Genomics Hum Genet2015https://conductscience.org/library/papers/25939054PubMed
1631088786Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.BMJ2019https://conductscience.org/library/papers/31088786PubMed
1734326189Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.Eur Respir J2022https://conductscience.org/library/papers/34326189PubMed
1836922753Comprehensive analysis of metabolic changes in spontaneously hypertensive rats.Clin Exp Hypertens2023https://conductscience.org/library/papers/36922753PubMed
1921288892Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.J Biol Chem2011https://conductscience.org/library/papers/21288892PubMed
2037422736Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis.Mayo Clin Proc2023https://conductscience.org/library/papers/37422736PubMed

See all 84 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GNPNAT164841PubTator's text mininghttps://conductscience.org/library/genes/64841NCBI Gene
QPCT25797PubTator's text mininghttps://conductscience.org/library/genes/25797NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39596173

GET https://conductscience.org/api/papers/v1/39596173/references?page=2